FMS:NYE-Fresenius Medical Care Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 21.31

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.34M

Analyst Target

USD 44.77
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 104.23B
UHS Universal Health Services Inc

N/A

USD 16.11B
THC Tenet Healthcare Corporation

N/A

USD 16.10B
DVA DaVita HealthCare Partners Inc

N/A

USD 13.68B
EHC Encompass Health Corp

N/A

USD 9.32B
CHE Chemed Corp

N/A

USD 8.90B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.96B
AMN AMN Healthcare Services Inc

N/A

USD 1.62B

ETFs Containing FMS

TPYP Tortoise North American P.. 3.89 % 0.40 %

N/A

N/A
RYU 3.37 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.85% 22% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.85% 22% F 9% A-
Trailing 12 Months  
Capital Gain -50.53% 22% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.53% 22% F 8% B-
Trailing 5 Years  
Capital Gain -67.32% 17% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -67.32% 17% F 7% C-
Average Annual (5 Year Horizon)  
Capital Gain -11.62% N/A N/A 6% D-
Dividend Return -9.15% N/A N/A 7% C-
Total Return 2.48% N/A N/A 53% F
Risk Return Profile  
Volatility (Standard Deviation) 26.72% N/A N/A 39% F
Risk Adjusted Return -34.24% N/A N/A 9% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector